Abstract
In this issue of Blood, Eisfeld and colleagues present strong evidence that miR-3151 and the host gene BAALC (brain and acute leukemia, cytoplasmic) concomitantly affect the outcome of patients with cytogenetically normal acute myeloid leukemia (CN-AML) by influencing significant signaling pathways.
Original language | English (US) |
---|---|
Pages (from-to) | 240-241 |
Number of pages | 2 |
Journal | Blood |
Volume | 120 |
Issue number | 2 |
DOIs |
|
State | Published - Jul 12 2012 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology